Andrew Karter to Angiotensin II Type 1 Receptor Blockers
This is a "connection" page, showing publications Andrew Karter has written about Angiotensin II Type 1 Receptor Blockers.
Connection Strength
0.060
-
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004 Jun; 19(6):669-75.
Score: 0.060